Caffeine in bronchiolitis associated apnea: A retrospective cohort study

Journal of Pediatric Intensive Care

Volumn 1, Issue 2, 2012, Pages 95-98

  Duffett, Mark ^a   Liu, Daisy M ^b   Deshpande, Ashish ^a   Choong, Karen ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b WESTERN UNIVERSITY   (Canada)

Author keywords

Apnea; Bronchiolitis; Caffeine; Critical care; Mechanical ventilation; Respiratory syncytial virus

Indexed keywords

EID: 85013582757     PISSN: 21464618     EISSN: 21464626     Source Type: Journal    
DOI: 10.3233/PIC-2012-016     Document Type: Article

References (17)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282(15): 1440-6.
2. Koehoorn M, Karr CJ, Demers PA, Lencar C, Tamburic L, Brauer M. Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics 2008; 122(6): 1196-203.
3. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995; 126(2): 212-9.
4. Kneyber MC, Brandenburg AH, de Groot R, Joosten KF, Rothbarth PH, Ott A, et al. Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr 1998; 157(4): 331-5.
5. Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med 2006; 48(4): 441-7.
6. Tripp RA, Dakhama A, Jones LP, Barskey A, Gelfand EW, Anderson LJ. The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. J Virol 2003; 77(11): 6580-4.
7. Anas N, Boettrich C, Hall CB, Brooks JG. The association of apnea and respiratory syncytial virus infection in infants. J Pediatr 1982; 101(1): 65-8.
8. Pickens DL, Schefft G, Thach BT. Prolonged apnea associated with upper airway protective reflexes in apnea of prematurity. Am Rev Respir Dis 1988; 137(1): 113-8.
9. Blum DJ, McCaffrey TV. Age-related responses of laryngeal airway resistance to peripheral and central chemoreceptor stimulation. Ann Otol Rhinol Laryngol 1984; 93(5 Pt 1): 488-93.
10. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med 2006; 354(20): 2112-21.
11. Henderson-Smart DJ, Steer P. Prophylactic caffeine to prevent postoperative apnea following general anesthesia in preterm infants. Cochrane Database Syst Rev 2001;(4): CD000048.
12. DeBuse P, Cartwright D. Respiratory syncytial virus with apnoea treated with theophylline. Med J Aust 1979; 2(6): 307-8.
13. Johnston DM, Kuzemko JA. Virus-induced apnoea and theophylline. Lancet 1992; 340(8831): 1352.
14. Sajit NT, Steggall M, Padmakumar B. Apnoeas in bronchiolitis: is there a role for caffeine? Arch Dis Child 2005; 90(4): 438.
15. Tobias JD. Caffeine in the treatment of apnea associated with respiratory syncytial virus infection in neonates and infants. South Med J 2000; 93(3): 294-6.
16. Yañez LJ, Yunge M, Emilfork M, Lapadula M, Alcántara A, Fernández C, et al. A prospective, randomized, controlled trial of noninvasive ventilation in pediatric acute respiratory failure. Pediatr Crit Care Med 2008; 9(5): 484-9.
17. Pollack MM, Patel KM, Ruttimann UE. The Pediatric Risk of Mortality III-Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr 1997; 131(4): 575-81.